EMPLOYMENT AGREEMENTEmployment Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • Missouri
EMPLOYMENT AGREEMENT (“Agreement”), dated as of January 11, 2010 (the “Effective Date”), made and entered into by and between K-V Pharmaceutical Company, a Delaware corporation (the “Company”), and Janice C. Forsyth (the “Executive”).
SEPARATION AGREEMENT AND GENERAL RELEASESeparation Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • Missouri
This Separation Agreement and General Release (“Agreement”) is entered into effective as of the 2nd day of September, 2009, by and between Ronald J. Kanterman (“Executive”) and KV Pharmaceutical Company, a Delaware corporation (the “Company” or “KV”, and, together with Executive, the “Parties”).
INCENTIVE STOCK OPTION AGREEMENT PURSUANT TOIncentive Stock Option Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations
INCENTIVE STOCK OPTION AGREEMENT (the “Agreement”) made as of the day of , 20 , (the “Grant Date”) between K-V PHARMACEUTICAL COMPANY, a Delaware corporation (the “Company”), and , an employee of the Company or of a subsidiary of the Company (the “Optionee”).
CONSULTING AND CONFIDENTIALITY AGREEMENTConsulting and Confidentiality Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • Missouri
This Agreement is entered into this 2d day of Sept., 2009 (“Effective Date”) by and between KV Pharmaceutical Company (“KV”), 2503 South Hanley Road, St. Louis, MO 63144, a Delaware corporation, and Ronald J. Kanterman, [Address intentionally omitted] (“Kanterman” or “Consultant”).
AGREEMENT AND RELEASESeverance Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • Missouri
This AGREEMENT AND RELEASE (hereinafter referred to as “Agreement”) is made and entered into this 2nd day of March, 2010, by and between Richard H. Chibnall (hereinafter “Releasee”), on his/her own behalf and KV PHARMACEUTICAL COMPANY (hereinafter “KV”).
January 8, 2010Asset Purchase Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations • Delaware
Pursuant to that certain Asset Purchase Agreement by and among K-V Pharmaceutical Company, a Delaware corporation (“Acquiror”), Cytyc Prenatal Products Corp., a Delaware corporation (“Cytyc”), and Hologic, Inc., a Delaware corporation (“Seller”), dated as of January 16, 2008 (as of immediately prior to the execution of this Amendment, the “Original Agreement”), and the disclosure schedule accompanying the Original Agreement (the “Disclosure Schedule”), the Acquiror and the Seller are entering into this amendment (this “Amendment”) to amend certain provisions of the Original Agreement and the Related Agreements as of the date hereof (the “Amendment Date”). In consideration of the terms set forth in this Amendment, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Acquiror and the Seller agree as follows:
NONQUALIFIED STOCK OPTION AGREEMENT PURSUANT TONonqualified Stock Option Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations
NONQUALIFIED STOCK OPTION AGREEMENT (the “Agreement”) made as of the day of , 20 , (the “Grant Date”) between K-V PHARMACEUTICAL COMPANY, a Delaware corporation (the “Company”), and , a member of the Company’s Board of Directors (the “Optionee”).
NONQUALIFIED STOCK OPTION AGREEMENT PURSUANT TONonqualified Stock Option Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations
NONQUALIFIED STOCK OPTION AGREEMENT (the “Agreement”) made as of the day of , 20 , (the “Grant Date”) between K-V PHARMACEUTICAL COMPANY, a Delaware corporation (the “Company”), and , an employee of the Company or of a subsidiary of the Company (the “Optionee”).
KV PHARMACEUTICAL COMPANY FOURTH AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • March 25th, 2010 • Kv Pharmaceutical Co /De/ • Pharmaceutical preparations
THIS FOURTH AMENDMENT (this “Fourth Amendment”) is made and entered into as of March 2, 2010, by and among RICHARD H. CHIBNALL (“Employee”) and KV PHARMACEUTICAL COMPANY, a Delaware corporation (“KV”).
